id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2000-N-0224-0004,FDA,FDA-2000-N-0224,Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Requirements for Submission of Labeling for Human Prescription Drugs and Biologics in Electronic Format; Notice of Approval,Notice,Notice of Approval,2003-12-16T05:00:00Z,2003,12,2003-12-16T05:00:00Z,,2015-12-09T14:52:39Z,,0,0,09000064804d542a
FDA-2000-N-0224-0003,FDA,FDA-2000-N-0224,Supporting Statement re: Requirements for Submission of Labeling for Human Prescription Drugs and Biologics in Electronic Format - Agency Information Collection Activities,Supporting & Related Material,Background Material,2003-12-16T05:00:00Z,2003,12,,,2015-12-09T14:45:25Z,,0,0,09000064804d5429
FDA-2000-N-0224-0002,FDA,FDA-2000-N-0224,Requirements for Submission of Labeling for Human Prescription Drugs and Biologics in Electronic Format; Final Rule,Notice,Notice of Final Rule,2003-12-12T05:00:00Z,2003,12,2003-12-09T05:00:00Z,,2015-11-17T15:33:29Z,,0,0,09000064804d5428